Ibuprofen Kruidvat

Ibuprofen, the active ingredient in Ibuprofen Kruidvat, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use. It relieves pain, reduces fever, and diminishes inflammation in adults and children when appropriate.

GNH USA supplies Ibuprofen Kruidvat as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Ibuprofen acts systemically to manage symptoms associated with inflammatory and febrile conditions.

Pain: Provides analgesic relief for mild to moderate musculoskeletal, dental, and headache pain. Fever: Lowers elevated body temperature in febrile illnesses. Inflammation: Reduces swelling and stiffness in conditions such as arthritis or minor injuries.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort such as dyspepsia or heartburn. - Nausea or mild vomiting. - Headache. - Dizziness. - Mild skin rash.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Renal impairment or acute kidney injury. - Severe hypersensitivity reactions, including anaphylaxis. - Hepatotoxicity. - Cardiovascular events such as myocardial infarction or stroke, especially with high‑dose or prolonged use.

Before using ibuprofen, consider the following safety measures.

Allergy assessment: Verify no known hypersensitivity to ibuprofen or other NSAIDs. Cardiovascular risk: Use the lowest effective dose for the shortest duration in patients with heart disease. Renal function: Monitor kidney function in individuals with pre‑existing renal impairment. Gastrointestinal health: Caution in patients with a history of ulcers or bleeding disorders. Pregnancy and lactation: Consult a healthcare professional before use during pregnancy or breastfeeding. Store at ambient temperature: Keep below 25 °C, retain in original packaging, and protect from moisture.

Ibuprofen may alter the activity of several other medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - High‑dose aspirin: heightened gastrointestinal toxicity. - Selective COX‑2 inhibitors: additive renal and cardiovascular hazards.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in antihypertensive effect and renal function. - Diuretics: may diminish diuretic efficacy and increase nephrotoxicity. - Lithium: ibuprofen can raise serum lithium levels, requiring monitoring.